Literature DB >> 22549973

Redox imbalance and pulmonary function in bleomycin-induced fibrosis in C57BL/6, DBA/2, and BALB/c mice.

Marco Aurélio Santos-Silva1, Karla Maria Pereira Pires, Eduardo Tavares Lima Trajano, Vanessa Martins, Renata Tiscoski Nesi, Cláudia Farias Benjamin, Maurício Silva Caetano, Cinthya Sternberg, Mariana Nascimento Machado, Walter Araújo Zin, Samuel Santos Valença, Luis Cristóvão Porto.   

Abstract

The development of bleomycin-induced pulmonary fibrosis (BLEO-PF) has been associated with differences in genetic background and oxidative stress status. The authors' aim was to investigate the crosstalk between the redox profile, lung histology, and respiratory function in BLEO-PF in C57BL/6, DBA/2, and BALB/c mice. BLEO-PF was induced with a single intratracheal dose of bleomycin (0.1 U/mouse). Twenty-one days after bleomycin administration, the mortality rate was over 50% in C57BL/6 and 20% in DBA/2 mice, and BLEO-PF was not observed in BALB/c. There was an increase in lung static elastance (p < .001), viscoelastic/inhomogeneous pressure (p < .05), total pressure drop after flow interruption (p < .01), and ΔE (p < .05) in C57BL/6 mice. The septa volume increased in C57BL/6 (p < .05) and DBA/2 (p < .001). The levels of IFN-γ were reduced in C57BL/6 mice (p < .01). OH-proline levels were increased in C57BL/6 and DBA/2 mice (p < .05). SOD activity and expression were reduced in C57BL/6 and DBA/2 mice (p < .001 and p < .001, respectively), whereas catalase was reduced in all strains 21 days following bleomycin administration compared with the saline groups (C57BL/6: p < .05; DBA/2: p < .01; BALB/c: p < .01). GPx activity and GPx1/2 expression decreased in C57BL/6 (p < .001). The authors conclude that BLEO-PF resistance may also be related to the activity and expression of SOD in BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22549973     DOI: 10.1177/0192623312441404

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  15 in total

1.  Age-dependent dysregulation of redox genes may contribute to fibrotic pulmonary disease susceptibility.

Authors:  Evan A Elko; J Matthew Mahoney; Pamela Vacek; Albert van der Vliet; Vikas Anathy; Jos L J L van der Velden; Yvonne M W Janssen-Heininger; David J Seward
Journal:  Free Radic Biol Med       Date:  2019-07-14       Impact factor: 7.376

2.  Pulmonary Emphysema Cross-Linking with Pulmonary Fibrosis and Vice Versa: a Non-usual Experimental Intervention with Elastase and Bleomycin.

Authors:  Isabella Cattani-Cavalieri; Adriane Graça Reis; Emanuel Kennedy-Feitosa; Vanessa Pinho-Ribeiro; Manuella Lanzetti; Lycia Brito Gitirana; Bruna Romana-Souza; Luis Cristóvão Porto; Samuel Santos Valença
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

3.  Mitochondrial catalase overexpressed transgenic mice are protected against lung fibrosis in part via preventing alveolar epithelial cell mitochondrial DNA damage.

Authors:  Seok-Jo Kim; Paul Cheresh; Renea P Jablonski; Luisa Morales-Nebreda; Yuan Cheng; Erin Hogan; Anjana Yeldandi; Monica Chi; Raul Piseaux; Karen Ridge; C Michael Hart; Navdeep Chandel; G R Scott Budinger; David W Kamp
Journal:  Free Radic Biol Med       Date:  2016-11-11       Impact factor: 7.376

4.  ASK1 Regulates Bleomycin-induced Pulmonary Fibrosis.

Authors:  Samuel S Valenca; Brittany E Dong; Elizabeth M Gordon; Ramon C Sun; Christopher M Waters
Journal:  Am J Respir Cell Mol Biol       Date:  2022-05       Impact factor: 7.748

Review 5.  Getting leukocytes to the site of inflammation.

Authors:  W A Muller
Journal:  Vet Pathol       Date:  2013-01       Impact factor: 2.221

6.  Tocopherol supplementation reduces NO production and pulmonary inflammatory response to bleomycin.

Authors:  Jin Dong Shi; Thea Golden; Chang-Jiang Guo; Shui Ping Tu; Pamela Scott; Mao-Jung Lee; Chung S Yang; Andrew J Gow
Journal:  Nitric Oxide       Date:  2013-05-10       Impact factor: 4.427

7.  Bach1 siRNA attenuates bleomycin-induced pulmonary fibrosis by modulating oxidative stress in mice.

Authors:  Yuan Liu; Yi Zheng
Journal:  Int J Mol Med       Date:  2016-12-08       Impact factor: 4.101

8.  Ang-(1-7) treatment attenuates lipopolysaccharide-induced early pulmonary fibrosis.

Authors:  Yongmei Cao; Yujing Liu; Jiawei Shang; Ziming Yuan; Feng Ping; Sijia Yao; Yong Guo; Yingchuan Li
Journal:  Lab Invest       Date:  2019-07-05       Impact factor: 5.662

9.  Increased MMP-9 levels with strain-dependent stress resilience and tunnel handling in mice.

Authors:  Kate Kennedy-Wood; Christi Anne S Ng; Seham Alaiyed; Patricia L Foley; Katherine Conant
Journal:  Behav Brain Res       Date:  2021-04-06       Impact factor: 3.352

10.  Hirsutella sinensis mycelium attenuates bleomycin-induced pulmonary inflammation and fibrosis in vivo.

Authors:  Tsung-Teng Huang; Hsin-Chih Lai; Yun-Fei Ko; David M Ojcius; Ying-Wei Lan; Jan Martel; John D Young; Kowit-Yu Chong
Journal:  Sci Rep       Date:  2015-10-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.